| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/29/2015 | US20150033382 Wheat cultivar wb6341 |
| 01/29/2015 | US20150033381 Wheat cultivar wb9518 |
| 01/29/2015 | US20150033380 Wheat cultivar wb9112 |
| 01/29/2015 | US20150033379 Wheat cultivar wb-deucecl+ |
| 01/29/2015 | US20150033378 Canola Variety Inbred NS6569 |
| 01/29/2015 | US20150033377 Canola Variety Inbred NS6703 |
| 01/29/2015 | US20150033376 Canola Variety Inbred NS6623 |
| 01/29/2015 | US20150033375 Canola Variety Inbred NS6266 |
| 01/29/2015 | US20150033374 Canola Variety Hybrid VR 9562 GC |
| 01/29/2015 | US20150033373 Canola Variety Hybrid VR 9561 GS |
| 01/29/2015 | US20150033372 Human VpreB & Chimaeric Surrogate Light Chains in Transgenic Non-Human Vertebrates |
| 01/29/2015 | US20150031871 RNA-Mediated Gene Modulation |
| 01/29/2015 | US20150031856 Anaplastic Lymphoma Kinase (ALK) As An Oncogene Capable Of Transforming Normal Human Cells |
| 01/29/2015 | US20150031855 Methods for Enhancing Bacterial Cell Display of Proteins and Peptides |
| 01/29/2015 | US20150031756 Lentiviral vectors and uses thereof |
| 01/29/2015 | US20150031755 Nucleic Acids Specifically Binding CGRP |
| 01/29/2015 | US20150031754 Aptamer modulators of estrogen receptors |
| 01/29/2015 | US20150031751 Compositions and methods for treatment of ovarian cancer |
| 01/29/2015 | US20150031750 Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf |
| 01/29/2015 | US20150031749 Biomarker, uses thereof and therapy |
| 01/29/2015 | US20150031748 Modulating the interaction between zo-2/tjp2 and a snail zinc finger transcription factor family member |
| 01/29/2015 | US20150031747 Methods and compositions for modulating factor vii expression |
| 01/29/2015 | US20150031746 Methods and compositions for neuroprotection |
| 01/29/2015 | US20150031745 Nanoconjugates able to cross the blood-brain barrier |
| 01/29/2015 | US20150031744 Method for predicting and detecting tumor metastasis |
| 01/29/2015 | US20150031743 Cell transfecting formulations of small interfering rna, related compositions and methods of making and use |
| 01/29/2015 | US20150031742 Treatment of uterine leiomyomata |
| 01/29/2015 | US20150031625 Targeted vectors for cancer immunotherapy |
| 01/29/2015 | US20150031622 Rhogef12 is a therapeutic target for the treatment of heart failure |
| 01/29/2015 | US20150031583 Phage display system |
| 01/29/2015 | US20150031564 Ligand having three finger structure and a method for detecting a molecule by using thereof |
| 01/29/2015 | US20150031549 Cellular High Throughput Encapsulation for Screening or Selection |
| 01/29/2015 | US20150031134 Crispr-cas component systems, methods and compositions for sequence manipulation |
| 01/29/2015 | US20150031133 Genome Engineering |
| 01/29/2015 | US20150031132 Genome Engineering |
| 01/29/2015 | US20150031129 Method for proliferating stem cells by activating c-met/hgf signaling and notch signaling |
| 01/29/2015 | US20150031116 Integrated active flux microfluidic devices and methods |
| 01/29/2015 | US20150031113 Polypeptides Having Endoglucanase Activity and Polynucleotides Encoding Same |
| 01/29/2015 | US20150031103 Novel promoter and use thereof |
| 01/29/2015 | US20150031101 Bacterial cell having enhanced succinic acid production and a method for producing the succinic acid using the same |
| 01/29/2015 | US20150031100 Compositions and methods for chemical reporter vectors |
| 01/29/2015 | US20150031090 Methods and compositions for targeted genomic deletion |
| 01/29/2015 | US20150031089 Dna assembly using an rna-programmable nickase |
| 01/29/2015 | US20150031083 Adenoviral-based biological delivery and expression system for use in the treatment of Osteoarthritis |
| 01/29/2015 | US20150031082 Polypeptides Having Beta-Glucosidase Activity, Beta-Xylosidase Activity, or Beta-Glucosidase Activity and Beta-Xylosidase Activity And Polynucleotides Encoding Same |
| 01/29/2015 | US20150031081 Methods and materials for reducing degradation of recombinant proteins |
| 01/29/2015 | US20150031080 Cellobiohydrolase variants and polynucleotides encoding same |
| 01/29/2015 | US20150031076 Transformed cells that ferment pentose sugars and methods of their use |
| 01/29/2015 | US20150031025 Genetic products differentially expressed in tumors and use thereof |
| 01/29/2015 | US20150030854 Vitamin b6-coupled poly(ester amine) as gene carrier and application in cancer gene therapy |
| 01/29/2015 | US20150030681 Method of making a hydrogel |
| 01/29/2015 | US20150030627 Trans-complementing, replication deficient lentiviral vectors and methods for making and using them |
| 01/29/2015 | US20150030624 Campylobacter Immunogenic Compositions and Uses Thereof |
| 01/29/2015 | US20150030623 Recombinant Feline Leukemia Virus Vaccine Containing Optimized Feline Leukemia Virus Envelope Gene |
| 01/29/2015 | US20150030605 Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof |
| 01/29/2015 | US20150030581 Lpl variant therapeutics |
| 01/29/2015 | US20150030576 Methods and compositions for targeting agents into and across the blood-brain barrier |
| 01/29/2015 | US20150030574 Cells genetically modified to comprise pancreatic islet glucokinase and uses thereof |
| 01/29/2015 | US20150030573 Bacterial mediated thf alpha gene silencing |
| 01/29/2015 | US20150030572 Identification of molecular pathways and methods of use thereof for treating retinal neurodegeneration and other neurodegenerative disorders |
| 01/29/2015 | US20150030570 Culture medium for preparing neural stem cells and use thereof |
| 01/29/2015 | US20150030562 Methods of treating or preventing viral diseases by blocking interleukin-21 |
| 01/29/2015 | DE102013107886A1 Biokatalysator zur Produktion von 16-beta-OH-Testosteron mittels rekombinanter Bacillus megaterium Stämme Biocatalyst for the production of 16-beta-OH testosterone by recombinant Bacillus megaterium strains |
| 01/29/2015 | DE102013107885A1 Biokatalysator zur Produktion von 25-OH-Vitamin D3 und anderen hydroxylierten Vitamin D3 Derivaten mittels rekombinanter Bacillus megaterium Stämme Biocatalyst for the production of 25-OH-vitamin D3 and other hydroxylated vitamin D3 derivatives by recombinant Bacillus megaterium strains |
| 01/29/2015 | CA2857802A1 Variety corn line hid3259 |
| 01/28/2015 | EP2829614A1 Method for detecting target nucleic acid molecule |
| 01/28/2015 | EP2829609A1 Human CTLA-4 antibodies and their uses |
| 01/28/2015 | EP2829608A1 Method for recombinant protein production in mammalian cells |
| 01/28/2015 | EP2829607A1 Gene encoding of enzyme for reducing position 24 of steroid skeleton and plant having reduced expression of same gene |
| 01/28/2015 | EP2829606A1 Method for producing viral vector |
| 01/28/2015 | EP2829605A1 Method for screening therapeutic and/or prophylactic agents for alzheimer's disease |
| 01/28/2015 | EP2829604A1 Device for target analysis of streptavidin, and analysis method |
| 01/28/2015 | EP2829603A1 Protein alignment method |
| 01/28/2015 | EP2829599A1 Method for introducing exogenous dna by overcoming restriction modification barrier of target bacterium |
| 01/28/2015 | EP2829550A2 Fusion proteins forming trimers |
| 01/28/2015 | EP2829549A2 Hybrid and tandem expression of neisserial derived proteins |
| 01/28/2015 | EP2829279A1 Modulation of cytokine-induced chronic inflammatory responses |
| 01/28/2015 | EP2829274A1 Vectors for producing and secreting substance of interest by bacteria and applications thereof |
| 01/28/2015 | EP2829173A1 Novel fungal strain for producing cellulase and saccharification method using same |
| 01/28/2015 | EP2828406A1 Molecular markers for low palmitic acid content in sunflower (helianthus annus), and methods of using the same |
| 01/28/2015 | EP2828389A1 Transgenic plants with altered nitrate levels in leaves |
| 01/28/2015 | EP2828388A1 Transgenic plants with altered nitrate levels in leaves |
| 01/28/2015 | EP2828387A1 Novel therapeutic target for the prevention of tumour metastasis |
| 01/28/2015 | EP2828386A1 RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX |
| 01/28/2015 | EP2828384A1 Method to overcome dna chemical modifications sensitivity of engineered tale dna binding domains |
| 01/28/2015 | EP2828332A1 Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo |
| 01/28/2015 | EP2828286A1 Transgenic plants having lower nitrate content in leaves |
| 01/28/2015 | EP2828285A1 Hb-egf inhibitor derived from the r domain of diphtheria toxin for the treatment of diseases associated with the activation of the hb-egf/egfr pathway |
| 01/28/2015 | EP2827893A1 Virus -like particles comprising a matrix protein from a plant enveloped virus and uses thereof |
| 01/28/2015 | EP2827706A1 Transgenic animal model of mood disorders |
| 01/28/2015 | EP2827702A1 Herbicide tolerant soybeans and methods of use |
| 01/28/2015 | CN1890262B 抗凝血酶Ⅲ组合物的制造方法 The method of producing the composition of antithrombin Ⅲ |
| 01/28/2015 | CN104321440A 来源于甘蔗野生种基因组的茎长相关标志物及其利用 Derived from wild species of sugarcane stem length genome associated markers and their utilization |
| 01/28/2015 | CN104321433A 植物的胁迫耐受 Stress tolerance in plants |
| 01/28/2015 | CN104321432A 包含5′top utr的人工核酸分子 Artificial nucleic acid molecule comprising a 5'top utr |
| 01/28/2015 | CN104321431A 在dna/rna应用中作为可裂解接头的逆狄尔斯阿尔德反应 In dna / rna applications as inverse Cordier de las cleavable linker response |
| 01/28/2015 | CN104321430A 新颖的抗-siglec-15抗体 Novel anti -siglec-15 antibody |
| 01/28/2015 | CN104321429A 经修饰的级联核糖核蛋白及其用途 Ribonucleoprotein modified cascade and its use |
| 01/28/2015 | CN104321426A 永生化干细胞以及以其生成物为有效成分的药物组合物和药物制剂 Immortalized stem cell and its product is an active ingredient of pharmaceutical compositions and pharmaceutical preparations |
| 01/28/2015 | CN104321420A 植物浸润设备 Invasive plant equipment |